0
Editor's Correspondence |

Amrinone and Amiodarone: Serious Confusion in the Intravenous Line

P. Timothy Pollak, MD, PhD; Susan Pierce, BSc, Pharm; Charmaine Cooke, BSc, Pharm
Arch Intern Med. 1998;158(2):193-194. doi:.
Text Size: A A A
Published online

Extract

We recently encountered a drug name confusion with an even higher potential for acutely catastrophic effects than the commonly cited Levoxine-Lanoxin confusion.1 A 60-year-old woman with atrial fibrillation (heart rate, 140-160/min) suffered a non–Q wave myocardial infarction in the intensive care unit (ICU) following emergency surgery for a superior mesenteric artery embolism. Attempts to induce sinus rhythm to improve her cardiac function failed despite the administration of intravenous procainamide hydrochloride and 2 attempts at electrocardioversion. Since the patient was taking nothing by mouth, a cardiology consultant prescribed intravenous amiodarone. Because the patient was not in the cardiac ICU, the nursing staff had no experience with amiodarone. They were, however, very familiar with amrinone, which was ward stock in their unit. Therefore, it was assumed that the physician's order read amrinone. Approximately 250 mg of amrinone was administered during the 4 hours before the pharmacy received the prescription and detected the medication error. The patient suffered from chest pain and tachycardia, but no permanent adverse effects were detected.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();